HA-33 facilitates transport of the serotype D botulinum toxin across a rat intestinal epithelial cell monolayer

FEMS Immunology and Medical Microbiology

Volumn 61, Issue 3, 2011, Pages 323-331

  Ito, Hiroaki ^a   Sagane, Yoshimasa ^b   Miyata, Keita ^a   Inui, Ken ^a   Matsuo, Tomohito ^a   Horiuchi, Ryohta ^a   Ikeda, Toshihiko ^c   Suzuki, Tomonori ^d   Hasegawa, Kimiko ^e   Kouguchi, Hirokazu ^f   Oguma, Keiji ^d   Niwa, Koichi ^a   Ohyama, Tohru ^a   Watanabe, Toshihiro ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^b Sars International Centre for Marine Molecular Biology   (Norway)

^c YOKOHAMA COLLEGE OF PHARMACY   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e RIGAKU CORPORATION   (Japan)

^f HOKKAIDO INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Clostridium botulinum; Haemaggulutinin; IEC 6; Intestinal epithelium; Neurotoxin; Toxin complex

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN D; HA 33; HEMAGGLUTININ; NEUROTOXIN; SIALIC ACID; UNCLASSIFIED DRUG;

ABSORPTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CELL TRANSPORT; CLOSTRIDIUM BOTULINUM TYPE D; CONTROLLED STUDY; INTESTINE EPITHELIUM CELL; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RAT; SEROTYPE;

ANIMALS; BOTULINUM TOXINS; CELL LINE; EPITHELIAL CELLS; PROTEIN TRANSPORT; RATS;

EID: 79952612789     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00779.x     Document Type: Article

References (37)

1. Bonventre PF (1979) Absorption of botulinal toxin from the gastrointestinal tract. Rev Infect Dis 1: 663-667.
2. Chen F, Kuziemko GM & Stevens RC (1998) Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species. Infect Immun 66: 2420-2425.
3. Couesnon A, Pereira Y & Popoff MR (2008) Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers. Cell Microbiol 10: 375-387.
4. East AK, Bhandari M, Stacey JM, Campbell KD & Collins MD (1996) Organization and phylogenetic interrelationships of genes encoding components of the botulinum toxin complex in proteolytic Clostridium botulinum types A, B, and F: evidence of chimeric sequences in the gene encoding the nontoxic nonhemagglutinin component. Int J Syst Bacteriol 46: 1105-1112.
5. Fujinaga Y, Inoue K, Watanabe S, Yokota K, Hirai Y, Nagamachi E & Oguma K (1997) The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin. Microbiology 143: 3841-3847.
6. Fujinaga Y, Inoue K, Watarai S et al. (2004) Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes. Microbiology 150: 1529-1538.
7. Halliwell G (1954) The action of proteolytic enzymes on Clostridium botulinum type A toxin. Biochem J 58: 4-8.
8. Hasegawa K, Watanabe T, Sato H et al. (2004) Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947. Protein J 23: 371-378.
9. Hasegawa K, Watanabe T, Suzuki T et al. (2007) A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms. J Biol Chem 282: 24777-24783.
10. Inoue K, Fujinaga Y, Watanabe T, Ohyama T, Takeshi K, Moriishi K, Nakajima H, Inoue K & Oguma K (1996) Molecular composition of Clostridium botulinum type A progenitor toxins. Infect Immun 64: 1589-1594.
11. Inui K, Ito H, Miyata K, Matsuo T, Horiuchi R, Ikeda T, Watanabe T, Ohyama T & Niwa K (2010) Involvement of sialic acid in transport of serotype C1 botulinum toxins through rat intestinal epithelial cells. J Vet Med Sci 72: 1251-1255.
12. Jin Y, Takegahara Y, Sugawara Y, Matsumura T & Fujinaga Y (2009) Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. Microbiology 155: 35-45.
13. Johnson EA & Bradshaw M (2001) Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective. Toxicon 39: 1703-1722.
14. Kouguchi H, Watanabe T, Sagane Y, Sunagawa H & Ohyama T (2002) In vitro reconstitution of the Clostridium botulinum type D progenitor toxin. J Biol Chem 277: 2650-2656.
15. Li L & Singh BR (1999) Structure-function relationship of clostridial neurotoxins. J Toxicol Toxin Rev 18: 95-112.
16. Maksymowych AB & Simpson LL (1998) Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells. J Biol Chem 273: 21950-21957.
17. Maksymowych AB & Simpson LL (2004) Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells. J Pharmacol Exp Ther 310: 633-641.
18. Maksymowych AB, Reinhard M, Malizio CJ, Goodnough MC, Johnson EA & Simpson LL (1999) Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade. Infect Immun 67: 4708-4712.
19. Matsumura T, Jin Y, Kabumoto Y, Takegahara Y, Oguma K, Lencer WI & Fujinaga Y (2008) The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell Microbiol 10: 355-364.
20. Montecucco C & Schiavo G (1994) Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 13: 1-8.
21. Mutoh S, Kouguchi H, Sagane Y, Suzuki T, Hasegawa K, Watanabe T & Ohyama T (2003) Complete subunit structure of the Clostridium botulinum type D toxin complex via intermediate assembly with nontoxic components. Biochemistry 42: 10991-10997.
22. Mutoh S, Suzuki T, Hasegawa K, Nakazawa Y, Kouguchi H, Sagane Y, Niwa K, Watanabe T & Ohyama T (2005) Four molecules of the 33 kDa haemagglutinin component of the Clostridium botulinum serotype C and D toxin complexes are required to aggregate erythrocytes. Microbiology 151: 3847-3858.
23. Nakamura T, Kotani M, Tonozuka T, Ide A, Oguma K & Nishikawa A (2009) Crystal structure of the HA3 subcomponent of Clostridium botulinum type C progenitor toxin. J Mol Biol 385: 1193-1206.
24. Nishikawa A, Uotsu N, Arimitsu H et al. (2004) The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells. Biochem Bioph Res Co 319: 327-333.
25. Niwa K, Koyama K, Inoue S, Suzuki T, Hasegawa K, Watanabe T, Ikeda T & Ohyama T (2007) Role of nontoxic components of serotype D botulinum toxin complex in permeation through a Caco-2 cell monolayer, a model for intestinal epithelium. FEMS Immunol Med Mic 49: 346-352.
26. Niwa K, Yoneyama T, Ito H et al. (2010) Sialic acid-dependent binding and transcytosis of serotype D botulinum neurotoxin and toxin complex in rat intestinal epithelial cells. Vet Microbiol 141: 312-320.
27. Ohishi I (1984) Oral toxicities of Clostridium botulinum type A and B toxins from different strains. Infect Immun 43: 487-490.
28. Ohishi I & Sakaguchi G (1980) Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes. Infect Immun 28: 303-309.
29. Ohishi I, Sugii S & Sakaguchi G (1977) Oral toxicities of Clostridium botulinum toxins in response to molecular size. Infect Immun 16: 107-109.
30. Rossetto O & Montecucco C (2007) Peculiar binding of botulinum neurotoxins. ACS Chem Biol 2: 96-98.
31. Sakaguchi G, Kozaki S & Ohishi I (1984) Structure and function of Clostridium botulinum toxins. Bacterial Protein Toxins (Alouf JE, Fehrenbach FJ, Freer JH & Jeljaszewicz J, eds), pp. 435-443. Academic Press, London.
32. Sakaguchi G, Sakaguchi S, Kamata Y, Tabita K, Asao T & Kozaki S (1990) Distinct characters of Clostridium botulinum type A strains and their toxin associated with infant botulism in Japan. Int J Food Microbiol 11: 231-241.
33. Sugawara Y, Matsumura T, Takegahara Y, Jin Y, Tsukasaki Y, Takeichi M & Fujinaga Y (2010) Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin. J Cell Biol 189: 691-700.
34. Sugii S, Ohishi I & Sakaguchi G (1977a) Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes. Infect Immun 16: 910-914.
35. Sugii S, Ohishi I & Sakaguchi G (1977b) Intestinal absorption of botulinum toxins of different molecular sizes in rats. Infect Immun 17: 491-496.
36. Uotsu N, Nishikawa A, Watanabe T, Ohyama T, Tonozuka T, Sakano Y & Oguma K (2006) Cell internalization and traffic pathway of Clostridium botulinum type C neurotoxin in HT-29 cells. Biochem Biophys Acta 1763: 120-128.
37. Zhou Y, Foss S, Lindo P, Sarkar H & Singh BR (2005) Hemagglutinin-33 of type A botulinum neurotoxin complex binds with synaptotagmin II. FEBS J 272: 2717-2726.